Chun Li

• Collaborate with the project manager to oversight the conduct of clinical trials and assure compliance with ICH-GCP guidelines and federal regulation • Conduct co-monitoring visits as part of internal quality management • Provide oversight and serve as quality control of the electronic Trial Master File of the CRO • Manage trial supply, study samples, and IPs • Review of study documents (e.g., protocols and informed consent templates) and study plans (e.g., cohort management plans and monitoring plans)

• Assessed adherence, efficacy and toxicity of oncology medications prior to patients' clinic appointment • Educated more than 15 patients about their oncology medications post-clinic • Developed tip sheets to help cancer patients choosing mobile health apps

• Antibiotic Stewardship Program - monitored patients to determine whether their current antibiotic medication regimen was appropriate or in need of adjustment based on indication and lab results • Infectious disease consultation – worked with infectious disease physicians and residents to provide counseling on antibiotic regimen

• Educated more than 20 patients about their medications before discharge • Monitored warfarin and vancomycin therapy for patients based on their lab values, adherence, and potential drug-drug interactions

• Researched on current treatment regimens for targeted disease states including acquired thrombotic thrombocytopenic purpura and hemophilia A • Analyzed and summarized current hemophilia A drug products on the market • Facilitated and educated other team members on the latest company’s trial information about drug products

• Determined warfarin dosing based on patient-specific INRs, assessed for significant drug-drug interactions with warfarin, and provided patient education on their diet and medication regimen • Monitored patients to determine whether their current medication regimen was appropriate or in need of adjustment based on advers effects and efficacy

• Monitored therapy for patients with hepatitis C based on their lab values, adherence, and potential drug-drug interactions • Provided medication reconciliation and education for patients during home visits